On June 12, 2026, Protara Therapeutics, Inc. held its Annual Meeting where stockholders voted on several proposals, including the election of directors and the amendment of the company's certificate of incorporation to increase authorized shares from 100 million to 200 million. Key votes included 26.7 million for Jesse Shefferman and 42.4 million for the share increase.